Search
Glaukos Corp
GKOSAdd to Watchlist
153.580USD
+1.525+1.00%
Close 07-24 16:00（ET）Quotes delayed by 15 min
8.83BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-24The current earnings forecast score of Glaukos Corp is 8.50, ranking 26 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 120.00, with a high of 165.00 and a low of 72.00.
Analyst Rating
Based on
15
analysts
Buy
Current Rating
165.000
Target Price
+8.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Glaukos Corp
GKOS
15
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
31
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Glaukos Corp's expected revenue for the next quarter?
Glaukos Corp's expected revenue is 150.98M.
What is Glaukos Corp's price target?
Analysts forecast that Glaukos Corp's price target is USD 120.00, with the highest forecast at USD 165.00 and the lowest forecast at USD 72.00.
How have Glaukos CorpGKOS's recent earnings per share performed?
The market expectation was USD -0.34, while Glaukos CorpGKOS's earnings per share (EPS) for the previous quarter was USD -2.32. EPS for the next quarter is expected at USD -0.22.
What is the analyst rating for Glaukos Corp?
Based on the ratings of Glaukos Corp's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.